[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100573114":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":22,"responsibleParty":40,"collaborators":7,"id":42,"slug":7,"hasResults":43,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":7,"eligibilityCriteria":47,"healthyVolunteers":43,"sex":48,"minAge":7,"maxAge":7,"enrollmentInfo":49,"targetDuration":7,"studyType":52,"phases":7,"briefSummary":53,"conditions":54,"keywords":56,"overallStatus":25,"whyStopped":7,"lastUpdateSubmitDate":58,"lastUpdatePostDateStruct":59,"startDateStruct":62,"completionDateStruct":64,"leadSponsor":66,"locationsCount":67},{"fullName":5,"class":6},"Rabin Medical Center","OTHER",null,[9],{"name":10,"affiliation":11,"role":12},"Sarah Elitzur, MD","Schneider Children'ds Medical Center","STUDY_DIRECTOR",[14,18],{"name":10,"role":15,"phone":16,"phoneExt":7,"email":17},"CONTACT","+97239253766","sarhae@clalit.org.il",{"name":19,"role":15,"phone":20,"phoneExt":7,"email":21},"Naomi Litichever, PhD","+97239253705","naomilitichever@clalit.org.il",[23],{"facility":24,"status":25,"city":26,"state":7,"zip":7,"country":27,"countryCode":28,"cosmosGeoPoint":29,"geoPoint":34,"contacts":35},"Schneider Children's Medical Center","RECRUITING","Petah Tikva","Israel","IL",{"type":30,"coordinates":31},"Point",[32,33],34.88747,32.08707,{"lat":33,"lon":32},[36,38],{"name":10,"role":15,"phone":37,"phoneExt":7,"email":17},"97239253766",{"name":19,"role":15,"phone":39,"phoneExt":7,"email":21},"97239253705",{"type":41,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100573114",false,"NCT06742073","Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome","Histiocytosis and Inflammatory Manifestations in Patients with H Syndrome- a Multinational Collaboration","Inclusion Criteria: Any patient with a genetically confirmed diagnosis of H syndrome -\n\nExclusion Criteria:\n\n\\-","ALL",{"count":50,"type":51},120,"ESTIMATED","OBSERVATIONAL","H syndrome is a rare genetic disorder predisposing to histiocytosis. Our knowledge of the clinical spectrum of these patients is based on case reports and small patient series. Patients with H syndrome have been treated with a range of immunomodulatory and chemotherapeutic agents, with limited success. We aim to comprehensively assess the clinical manifestations and patterns of treatment response in a multinational cohort of patients with H syndrome.",[55],"H Syndrome",[57],"SLC29A3","2024-12-15",{"date":60,"type":61},"2024-12-19","ACTUAL",{"date":63,"type":61},"2024-11-01",{"date":65,"type":51},"2026-08-01",{"name":5,"class":6},1]